This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...